[go: up one dir, main page]

HUE066433T2 - Proteáz inhibitort tartalmazó készítmények, azokat tartalmazó összetevõk, valamint eljárások azok elõállítására és felhasználására - Google Patents

Proteáz inhibitort tartalmazó készítmények, azokat tartalmazó összetevõk, valamint eljárások azok elõállítására és felhasználására

Info

Publication number
HUE066433T2
HUE066433T2 HUE22162188A HUE22162188A HUE066433T2 HU E066433 T2 HUE066433 T2 HU E066433T2 HU E22162188 A HUE22162188 A HU E22162188A HU E22162188 A HUE22162188 A HU E22162188A HU E066433 T2 HUE066433 T2 HU E066433T2
Authority
HU
Hungary
Prior art keywords
same
compositions
producing
methods
protease inhibitor
Prior art date
Application number
HUE22162188A
Other languages
English (en)
Inventor
Avraham Hershko
Miriam Kidron
Original Assignee
Oramed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oramed Ltd filed Critical Oramed Ltd
Publication of HUE066433T2 publication Critical patent/HUE066433T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
HUE22162188A 2012-02-01 2013-01-31 Proteáz inhibitort tartalmazó készítmények, azokat tartalmazó összetevõk, valamint eljárások azok elõállítására és felhasználására HUE066433T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261632868P 2012-02-01 2012-02-01
US201261634753P 2012-03-06 2012-03-06

Publications (1)

Publication Number Publication Date
HUE066433T2 true HUE066433T2 (hu) 2024-08-28

Family

ID=48904507

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE22162188A HUE066433T2 (hu) 2012-02-01 2013-01-31 Proteáz inhibitort tartalmazó készítmények, azokat tartalmazó összetevõk, valamint eljárások azok elõállítására és felhasználására

Country Status (9)

Country Link
US (4) US10342764B2 (hu)
EP (2) EP2814504B1 (hu)
JP (3) JP6567827B2 (hu)
CN (3) CN113769074A (hu)
DK (2) DK4082530T5 (hu)
ES (1) ES2912138T3 (hu)
HK (1) HK1200727A1 (hu)
HU (1) HUE066433T2 (hu)
WO (1) WO2013114369A1 (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180228621A1 (en) 2004-08-09 2018-08-16 Mark A. Reiley Apparatus, systems, and methods for the fixation or fusion of bone
ES2670856T3 (es) * 2005-09-06 2018-06-01 Oramed Pharmaceuticals Inc. Métodos y composiciones para la administración oral de proteínas
RU2504373C2 (ru) 2008-03-26 2014-01-20 ОРАМЕД Лтд. Способы и композиции для перорального введения протеинов
BRPI0908292B1 (pt) 2008-05-05 2022-09-20 Oramed Ltd Métodos e composições para administração oral de exenatida
JP6174601B2 (ja) 2012-01-03 2017-08-02 オラムド エルティーディー． 糖尿病を処置するための方法及び組成物
WO2013114369A1 (en) 2012-02-01 2013-08-08 Oramed Ltd Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
US10363140B2 (en) 2012-03-09 2019-07-30 Si-Bone Inc. Systems, device, and methods for joint fusion
WO2013134670A1 (en) 2012-03-09 2013-09-12 Si-Bone Inc. Integrated implant
WO2013166496A1 (en) 2012-05-04 2013-11-07 Si-Bone Inc. Fenestrated implant
US20150335715A1 (en) 2013-01-03 2015-11-26 Oramed Ltd. Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereof
US9936983B2 (en) 2013-03-15 2018-04-10 Si-Bone Inc. Implants for spinal fixation or fusion
US11147688B2 (en) 2013-10-15 2021-10-19 Si-Bone Inc. Implant placement
US10166033B2 (en) 2014-09-18 2019-01-01 Si-Bone Inc. Implants for bone fixation or fusion
EP4599780A3 (en) 2014-09-18 2025-10-29 SI-Bone, Inc. Matrix implant
CN105343184A (zh) * 2015-12-01 2016-02-24 无限极（中国）有限公司 一种组合物及其应用
WO2017161184A1 (en) * 2016-03-16 2017-09-21 Amidebio, Llc Methods for producing peptides and uses thereof
EP3687422A4 (en) 2017-09-26 2021-09-22 SI-Bone, Inc. SYSTEMS AND PROCESSES FOR DECORTICATION OF THE SACROILIAC JOINT
ES3011907T3 (en) 2018-03-28 2025-04-08 Si Bone Inc Threaded implants for use across bone segments
CA3096004A1 (en) * 2018-06-11 2019-12-19 Oramed Ltd. Recombinant protease inhibitor-containing compositions, methods for producing same and uses thereof
AU2020223180B2 (en) 2019-02-14 2025-09-25 Si-Bone Inc. Implants for spinal fixation and or fusion
US11369419B2 (en) 2019-02-14 2022-06-28 Si-Bone Inc. Implants for spinal fixation and or fusion
US12419668B2 (en) 2019-11-21 2025-09-23 Si-Bone Inc. Rod coupling assemblies for bone stabilization constructs
AU2020392121B2 (en) 2019-11-27 2025-05-22 Si-Bone, Inc. Bone stabilizing implants and methods of placement across SI joints
EP4072452A4 (en) 2019-12-09 2023-12-20 SI-Bone, Inc. SACROILIAC JOINT STABILIZATION IMPLANTS AND METHODS OF IMPLANTATION
JP2023553120A (ja) 2020-12-09 2023-12-20 エスアイ－ボーン・インコーポレイテッド 仙腸関節安定化インプラントおよびインプラント方法
GB202019817D0 (en) * 2020-12-15 2021-01-27 Univ Oxford Innovation Ltd Ligand-binding polypeptides and uses thereof
WO2023017537A1 (en) * 2021-08-12 2023-02-16 Celagenex Research (India) Pvt. Ltd. Oral algal oil based gastro-intestinal tract permeable peptide composition
WO2023102533A1 (en) 2021-12-03 2023-06-08 Si-Bone Inc. Fusion cages and methods for sacro-iliac joint stabilization
CN117186237A (zh) * 2022-05-29 2023-12-08 中国医学科学院药物研究所 一种含有糜蛋白酶抑制肽的胰岛素杂交肽及其应用
US12433733B2 (en) 2023-08-15 2025-10-07 Si-Bone Inc. Pelvic stabilization implants, methods of use and manufacture
WO2025152922A1 (zh) * 2024-01-15 2025-07-24 合肥天汇生物科技有限公司 使用分离的bbi和kti的多肽组合物及其用途

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL68769A (en) 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
JPS6350793A (ja) 1986-08-20 1988-03-03 株式会社東芝 高速増殖炉の崩壊熱除去システム
US5034415A (en) 1987-08-07 1991-07-23 Century Laboratories, Inc. Treatment of diabetes mellitus
ES2045276T3 (es) 1988-07-21 1994-01-16 Hoffmann La Roche Preparacion de insulina
JPH02250823A (ja) 1989-03-24 1990-10-08 Tsumura & Co マイクロカプセル剤およびその製造方法
GB9007052D0 (en) 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5206219A (en) 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
JPH06145198A (ja) * 1992-03-30 1994-05-24 Shokuhin Sangyo High Separeeshiyon Syst Gijutsu Kenkyu Kumiai 大豆トリプシンインヒビターの製造方法
US6692766B1 (en) 1994-06-15 2004-02-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Controlled release oral drug delivery system
US5824638A (en) 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
IL114673A (en) 1995-07-19 2000-12-06 Hadasit Med Res Service Pharmaceutical compositions containing protein for oral administration
JPH09208485A (ja) 1996-01-31 1997-08-12 Teijin Ltd ペプチド・蛋白質性薬物の水難溶性組成物
ES2319936T5 (es) 1996-08-08 2013-06-24 Amylin Pharmaceuticals, Inc. Regulación de la motilidad gastrointestinal
JPH10330287A (ja) 1997-03-31 1998-12-15 Nippon Suisan Kaisha Ltd 多価不飽和脂肪酸からなる消化管吸収促進剤およびそれを含有する薬剤
JP2000128805A (ja) 1998-10-27 2000-05-09 Nippon Suisan Kaisha Ltd 多価不飽和脂肪酸および高分子ゲルからなる経粘膜吸収促進剤及びそれを含有する薬剤
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
JP2001240558A (ja) 2000-02-29 2001-09-04 Nippon Suisan Kaisha Ltd 多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
US6673574B2 (en) 2000-11-30 2004-01-06 Unigene Laboratories Inc. Oral delivery of peptides using enzyme-cleavable membrane translocators
KR20010069322A (ko) 2001-03-08 2001-07-25 서종수 휴대형정보단말기 또는 화상이동통신장치를 이용한전자경매방법
KR20010069433A (ko) 2001-03-22 2001-07-25 김윤완 노루궁뎅이버섯을 이용한 건강 보조 식품
CN1160122C (zh) * 2001-04-20 2004-08-04 清华大学 一种制备口服胰岛素油相制剂的方法
EP1414474A4 (en) 2001-07-18 2005-06-29 Solae Llc PROTEIN BOWMAN BIRK HEMMER CONCENTRATE AND MANUFACTURING METHOD THEREFOR
US20030198666A1 (en) 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
JP4165329B2 (ja) * 2002-07-31 2008-10-15 不二製油株式会社 大豆ホエー分画物の製造法
US7767828B2 (en) 2003-11-12 2010-08-03 Phenomix Corporation Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
US20060286129A1 (en) 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
US20050143303A1 (en) 2003-12-26 2005-06-30 Nastech Pharmaceutical Company Inc. Intranasal administration of glucose-regulating peptides
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
CA2563533C (en) 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
CN103223160B (zh) 2004-07-19 2015-02-18 比奥孔有限公司 胰岛素-低聚物共轭物,制剂及其用途
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
DE602004015169D1 (de) 2004-11-26 2008-08-28 Nutricia Nv Kleinkindernahrung mit proteasehemmer
ES2670856T3 (es) 2005-09-06 2018-06-01 Oramed Pharmaceuticals Inc. Métodos y composiciones para la administración oral de proteínas
US20070086972A1 (en) 2005-09-12 2007-04-19 Jacob Birnbaum Hair growth compositions and methods for treating hair loss or related conditions
US20070077283A1 (en) 2005-09-30 2007-04-05 Nastech Pharmaceutical Company Inc. Method of enhancing transmucosal delivery of therapeutic compounds
CN101095942B (zh) 2006-06-30 2011-11-16 北京民海生物科技有限公司 一种包含稳定剂的Exendin-4注射剂药物配方
RU2504373C2 (ru) 2008-03-26 2014-01-20 ОРАМЕД Лтд. Способы и композиции для перорального введения протеинов
BRPI0908292B1 (pt) 2008-05-05 2022-09-20 Oramed Ltd Métodos e composições para administração oral de exenatida
SG192405A1 (en) 2008-06-17 2013-08-30 Univ Indiana Res & Tech Corp Gip-based mixed agonists for treatment of metabolic disorders and obesity
CN102123697B (zh) 2008-08-18 2015-06-10 安特拉贝欧有限公司 用于口服给予蛋白质的方法和组合物
US20120329993A1 (en) 2009-12-30 2012-12-27 Legal Department Soy whey protein compositions and methods for recovering same
JP6174601B2 (ja) * 2012-01-03 2017-08-02 オラムド エルティーディー． 糖尿病を処置するための方法及び組成物
WO2013114369A1 (en) * 2012-02-01 2013-08-08 Oramed Ltd Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
US20150335715A1 (en) 2013-01-03 2015-11-26 Oramed Ltd. Methods and compositions for treating nafld, hepatic steatosis, and sequelae thereof
CA3096004A1 (en) 2018-06-11 2019-12-19 Oramed Ltd. Recombinant protease inhibitor-containing compositions, methods for producing same and uses thereof

Also Published As

Publication number Publication date
ES2912138T3 (es) 2022-05-24
US20240358647A1 (en) 2024-10-31
EP4082530A1 (en) 2022-11-02
CN112755002A (zh) 2021-05-07
EP2814504A4 (en) 2015-10-14
EP2814504B1 (en) 2022-03-16
DK2814504T3 (da) 2022-05-02
HK1200727A1 (en) 2015-08-14
CN104244969A (zh) 2014-12-24
US10933022B2 (en) 2021-03-02
DK4082530T3 (da) 2024-05-06
US20210369626A1 (en) 2021-12-02
JP7064226B2 (ja) 2022-05-10
CN113769074A (zh) 2021-12-10
EP2814504A1 (en) 2014-12-24
US10342764B2 (en) 2019-07-09
US20190321303A1 (en) 2019-10-24
US20140377344A1 (en) 2014-12-25
DK4082530T5 (da) 2024-07-22
WO2013114369A1 (en) 2013-08-08
EP4082530B1 (en) 2024-04-10
JP2020117518A (ja) 2020-08-06
JP2018104443A (ja) 2018-07-05
JP6567827B2 (ja) 2019-08-28
JP2015510506A (ja) 2015-04-09

Similar Documents

Publication Publication Date Title
HUE066433T2 (hu) Proteáz inhibitort tartalmazó készítmények, azokat tartalmazó összetevõk, valamint eljárások azok elõállítására és felhasználására
IL238958A0 (en) Glutamase inhibitors, preparations containing them and their uses
IL237625A0 (en) Antibodies against m-cam, preparations containing them and their uses
IL238959A (en) Glutamase suppressors, preparations containing them and their uses
IL234014A (en) Cycloalkane derivatives, preparations containing them and their uses
GB201209268D0 (en) Surfactant composition
ZA201408594B (en) Xylitol-based anti-mucosal compositions and related methods and compositions
IL235004A0 (en) Antibodies against fgfr2, preparations containing them and their uses
ZA201308705B (en) Nutritional compositions for enhancing performance and methods for making and using same
SG10201702263QA (en) Compositions and methods for producing chemicals and derivatives thereof
IL236463A0 (en) Bifluorodioxalan-amino-benzaimidazole compounds, preparations containing them, methods for their production and their uses
MY156744A (en) Antioxidant, antioxidant composition, and method producing the same
IL233824A (en) Compounds 1h - Indazole - 3 - Carboxamide, preparations containing them and their use
ZA201407455B (en) Composition comprising herbs
GB201315350D0 (en) Methods and compositions
IL237542A0 (en) Amphiphilic compounds, their preparations and uses
GB201315347D0 (en) Methods and compositions
ZA201308892B (en) Compositions and methods
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
IL233682A0 (en) Modified phenylazole derivatives, preparations containing them and their uses
PL2893027T3 (pl) Kompozycje o poprawionej stabilności matrycy i sposoby
IL267888B (en) Amphiphilic compounds, their preparations and uses
IL237540A0 (en) Amphiphilic compounds, their preparations and uses
GB201222820D0 (en) Woolscouring method and composition
GB201208384D0 (en) Vesicular formulations, uses and methods